Hosted on MSN19m
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched StudyIn a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel, Carvykti) demonstrated better efficacy than idecabtagene vicleucel (ide-cel, Abecma) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback